Erschienen in:
04.06.2019 | Original Contributions
Effects of Chronic Corticosteroid and Immunosuppressant Use in Patients Undergoing Bariatric Surgery
verfasst von:
Joshua Hefler, Jerry Dang, Aryan Modasi, Noah Switzer, Daniel W. Birch, Shahzeer Karmali
Erschienen in:
Obesity Surgery
|
Ausgabe 10/2019
Einloggen, um Zugang zu erhalten
Abstract
Background
Chronic immunosuppression can put surgical patients at additional risk for complications, particularly infection. This is not a contraindication for patients undergoing bariatric surgery. However, with the increasing prevalence of bariatric surgery, it is important to characterize the additional risks for immunosuppressed patients.
Methods
The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) data registry was used to identify immunosuppressed patients who had undergone bariatric surgery. Patients undergoing primary bariatric surgery (laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy) at an accredited institution between 2015 and 2017 were included. A multivariable regression analysis was performed, controlling for age, sex, procedure, and several other comorbidities. Overall 30-day incidence of major complications was the primary outcome. A secondary analysis compared outcomes amongst immunosuppressed patients by procedure type using a propensity-matched analysis. Propensity matching was performed based on preoperative comorbidities and bariatric procedure.
Results
A total of 430,936 patients were included in the study. Of these, 7214 (1.7%) were chronically immunosuppressed. Our multivariable regression analysis found statistically higher odds of 30-day major complications (OR 1.39, 95% CI 1.25–1.55; p < 0.001), bleed (OR 1.49, 95% CI 1.24–1.80; p < 0.001) and anastomotic leak (OR 1.38, 95% CI 1.02–1.87; p = 0.037) amongst immunosuppressed patients. However, there was no difference between 30-day mortality (OR 1.15, 95% CI 0.64–2.07; p = 0.644). Our secondary analysis found higher rates of 30-day major complications for immunosuppressed patients undergoing gastric bypass (9.6% vs. 5.0%; p < 0.001).
Conclusion
Immunosuppressed patients are at higher risk of major complications when undergoing bariatric surgery, especially gastric bypass.